Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 03 August, 2012 and appeared in  Physical ActivityPathologyIssue 637

Endurance Training Cuts Lipid-Induced Insulin Resistance

Endurance training seems to lessen the effect of lipid-induced insulin resistance, specifically by preventing lipid-induced reduction in nonoxidative glucose disposal (NOGD)....

Advertisement

Esther Phielix, from the Maastricht University Medical Center in the Netherlands, and colleagues examined whether high oxidative capacity, seen in endurance-trained athletes, could attenuate lipid-induced insulin resistance. The study included nine endurance-trained and 10 untrained subjects, Participants underwent a clamp with infusion of glycerol or intralipid.

The researchers found that trained athletes had significantly higher mitochondrial capacity and insulin sensitivity (~32 and ~22 percent, respectively). Insulin-stimulated glucose uptake was reduced by lipid infusion by 63 percent in untrained subjects, and this effect was attenuated in trained subjects (29 percent). Lipid infusion reduced oxidative and NOGD in untrained subjects, while trained subjects were protected from lipid-induced reduction in NOGD.

"Overall, from the current study, we conclude that chronic exercise training attenuates lipid-induced insulin resistance by preventing a reduction in NOGD," the authors write. "In the future, more mechanistic studies are needed to fully understand the mechanism by which endurance training affects lipid-induced NOGD."

Diabetes, July 10, 2012

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 03 August, 2012 and appeared in  Physical ActivityPathologyIssue 637

Past five issues: Diabetes Clinical Mastery Series Issue 141 | Issue 681 | Diabetes Clinical Mastery Series Issue 140 | Issue 680 | Diabetes Clinical Mastery Series Issue 139 |

 
Diabetes In Control Advertisers
 
Cast Your Vote
If the FDA relaxes prescribing restrictions on Avandia, will you recommend it?

Navigate Diabetes In Control
Search Articles On Diabetes In Control